Cargando…
Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response
Bipolar disorder (BD) is a common, severe mental disorder with a high recurrence rate. Lithium (Li) is the cornerstone of BD treatments to reduce recurrence, suicide, and mortality risks. However, only 30% of patients treated with Li achieve complete remission, and few markers of the response to tre...
Autores principales: | Geoffroy, Pierre Alexis, Etain, Bruno, Sportiche, Sarah, Bellivier, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447721/ https://www.ncbi.nlm.nih.gov/pubmed/26092399 http://dx.doi.org/10.1186/2194-7511-2-5 |
Ejemplares similares
-
Genetic association study of circadian genes with seasonal pattern in bipolar disorders
por: Geoffroy, Pierre Alexis, et al.
Publicado: (2015) -
Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
por: Marie-Claire, Cynthia, et al.
Publicado: (2022) -
Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?
por: Scott, Jan, et al.
Publicado: (2018) -
Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium
por: Grillault Laroche, Diane, et al.
Publicado: (2020) -
Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study
por: Marie-Claire, C., et al.
Publicado: (2023)